Jennifer Shepphird, PhD | Authors

Articles

Cirmtuzumab Blocks Ovarian Cancer Metastasis in Preclinical Study

November 18, 2014

The monoclonal antibody cirmtuzumab, currently in clinical trials to treat CLL, targets ROR1 on the surface of cancerous B cells, and the agent may have a wider reach in the treatment of ovarian and other cancers.

HIV Has Role in CAR-T Therapy

November 13, 2014

Recent news stories profiling a cancer patient whose last hope rests on treatment by injections of the virus that causes AIDS may have created some misconceptions regarding a new cancer immunotherapy.